Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Lung Cancer|Soft Tissue Sarcoma|Colorectal Carcinoma|Breast Cancer|Prostate Cancer
Interventions: DRUG: Lonafarnib|DRUG: Docetaxel
Sponsor: Emory University
Collaborators: Aventis Pharmaceuticals|Schering-Plough